At Mass General, Scott Plotkin, MD, PhD, and Vijaya Ramesh, PhD, are using their respective expertise in clinical and fundamental science to investigate new treatments for neurofibromatosis and two related disorders.
Donor commitment allows rare disease research breakthrough, providing insights into Parkinson’s and other movement disorder diseases.
Genetic insights into rare diseases and new models of collaborative research that involve patients, clinicians, scientists and members of industry could produce much-needed new treatments.
Mass General researchers have developed a forecasting model for predicting future migraine attacks based on current levels of stress and head pain.
Invented at Mass General, a technology called fMRI continues to have a revolutionary impact on brain science and patient care.
Mass General ALS experts believe the new ALS House Call Program will help to change the course of medical care planning and improve outcomes for people with amyotrophic lateral sclerosis.
Mass General experts discussed progress towards understanding, treating and preventing brain disorders at the 12th annual Phillips Society luncheon.
Mass General researchers advance understanding of Parkinson’s disease in their search for a cure.
Mass General researchers are exploring the genetic mechanisms of ALS in their quest to develop effective treatments.
A Mass General sleep expert discusses insomnia, its symptoms and the evidence about whether taking a drug for treatment is worth the risk.